TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has released a detailed look its upcoming financial report along with strategic priorities and organizational alignment for 2022 as well as the calendar year of 2023, including formal guidance with respect to its forecasted revenue and sales. In the announcement, TOBAF stated that is building upon the company’s existing 2,700-store U.S. footprint, noting that its robust sales pipeline is expected to fortify overall revenues long-term. Highlights of the expected report include the company’s projection to generate substantial revenue growth, due to its acquisition of HLND Holdings Inc. and repeat orders of TAAT(R). In addition, the company plans to continue to commercialize TAAT(R) as a “category-creating” brand and broaden its domestic distribution in the United States. The company is also consistently working to identify expansion opportunities. In addition, TAAT noted that its formal guidance for revenue and sales had been updated, with the company’s anticipated revenues for fiscal year ending Oct. 31, 2022, reaching an estimated CAD$92,000,000 with continued quarterly losses through the remainder of 2022 as the company continues to invest in brand building, distribution and development of its nationwide sales network. “In the approximately 18 months since TAAT was first launched in the United States, we have established a solid foundation through strong execution of our priorities as well as continued attention to research and development,” said TAAT founder Joe Deighan in the press release. “The advanced formulation of Beyond Tobacco, known as V3, has proven exceptionally popular among adult smokers, and we have proactively taken steps to replace inventory of TAAT made with previous iterations, thus ensuring that V3 is as widely available as possible. Our acquisition of ADCO provides us more than just distribution bandwidth . . . . and perhaps most exciting, we are branching out into segments that complement our core offerings, such as TAAT heat-not-burn as well as a zero-hemp formulation of Beyond Tobacco(TM) that can enable us to commercialize TAAT more broadly at a global level.”
To view the full press release, visit https://ibn.fm/gCcGP
About TAAT Global Alternatives Inc.
TAAT develops, manufactures and distributes alternative products in categories to include tobacco, hemp, kratom and other emerging segments of the CPG industry. Its flagship product is a nicotine-free, tobacco-free cigarette with a patent-pending base material formulation, sold in more than 2,700 U.S. stores. TAAT reported an estimated C$80 million in overall net revenue in 2021 and operates a manufacturing plant in Nevada as well as a distribution center and multiple convenience stores in Ohio. For more information, please visit www.TAATGlobal.com.
NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
